Rheumatology

FDA approved test catches novel rheumatoid arthritis markers before it's too late.

The significant changes in the way rheumatoid arthritis has been managed include earlier, more aggressive treatment with combination therapy.

Further evaluation of reasons for treatment nonadherence in patients with rheumatologic disease is key in the development of successful interventions. Patient education efforts alone are not sufficient to improve adherence; complex interventions are most effective.

Specialists discuss what if any effect chondroitin and glucosamine have on osteoarthritis.

World Arthritis Day 2010 is today, so here are some arthritis health tips.

Diverse mechanisms of pathogenesis have been proposed for the autoimmune diseases. A growing body of medical literature suggests a potential effect of occupational exposures on their development.

FDA sends Jazz Pharmaceuticals a complete response letter for fibromyalgia drug JZP-6.

European Union okays Vimovo for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis

Hip injuries are common in dancers, runners, and soccer players. Knowledge of the mechanism of injury and the sport can help uncover the diagnosis. Muscular strength testing should be performed on the cardinal movements of the hip joint.

Persons who have arthritis often avoid exercise for fear of pain or injury or not wanting to make a lifestyle change.

Generalized bone mineral density (BMD) may be used as a predictor of subsequent radiographic damage in African Americans who have recent-onset rheumatoid arthritis (RA).

This podcast offers advice on how patients can manage their arthritis and relieve their pain.

With statistics released yesterday revealing arthritis cases are expected to grow, The Arthritis Foundation reacts.

Martial arts fall training may reduce the risk of hip fractures in persons with osteoporosis. Training is safe if they wear hip protectors that could attenuate the maximum hip impact force by at least 65%, perform the fall exercises on a thick mattress, and avoidforward fall exercises from a standing position.

Through 2030, the prevalence of arthritis is expected to rise significantly and obesity may be a factor.

Novartis' experimental drug treats three autoimmune disorders.

The presence of 4 or more of 8 clinical findings-multiple attacks of acute arthritis, rapid pain and swelling, monarthritis or oligoarthritis or both, podagra, erythema, tophi, unilateral attacks, and hyperuricemia-is highly suggestive of a diagnosis of gout when monosodium urate (MSU) crystals in synovial fluid or tophi cannot be demonstrated.

Study reveals pain diary increases perception of pain severity.

This podcast discusses the difficulties associated with failing to treat RA early on.

Instrinsic connectivity is disrupted within multiple brain networks in patients with fibromyalgia syndrome (FMS). Elevated intrinsic brain connectivity is linked with spontaneous pain intensity in these patients.

MDNG: Pain Management Edition is seeking nominations for the 2010 Pain Innovators of the Year Awards.

Physical therapy may provide benefits to those suffering from Rheumatic disease, according to the American College of Rheumatology.

Use of the patient-focused measurements derived from the Symptom Burden Index (SBI) instrument may help physicians providing care to patients with systemic sclerosis (SSc) resolve the problems that most directly affect their quality of life.

A phase II clinical study began for Galapagos NV's drug candidate GLPG0259, a novel drug being developed for rheumatoid arthritis.

CG100649, the first-in-class NSAID "tissue selective" drug candidate, will be discussed at conference.

The risk of all-cause mortality in US men is inversely associated with the number of their positive health factors. Targeting more of the modifiable health factors in middle-aged men may provide them with substantial health benefits.

A second biologic option is now available for patients in New Zealand with forms of arthritis.

Antibodies against peptidyl arginine deiminase type 4 are a specific early marker of rheumatoid arthritis.

In observance of World Arthritis Day, the Arthritis Foundation requests that all Americans "Do Blue" on Tuesday, October 12.

The results of a small, phase II clinical trial found substantial improvement in patient conditions when treated with tanezumab.